These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6242777)

  • 1. Continuous subcutaneous insulin infusion (CSII): therapeutic options.
    Ward JD
    Diabet Med; 1984 May; 1(1):47-50. PubMed ID: 6242777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous subcutaneous insulin infusion].
    Araki H; Makino H; Yoshida S
    Nihon Rinsho; 1990 Dec; 48 Suppl():1038-43. PubMed ID: 2086865
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion as a treatment option: a perspective after seven years of research applications.
    Pickup JC
    Diabet Med; 1984 May; 1(1):27-32. PubMed ID: 6242772
    [No Abstract]   [Full Text] [Related]  

  • 4. Complication of CSII.
    Colagiuri S; Kotowicz M
    Diabetes Care; 1984; 7(4):397-8. PubMed ID: 6468235
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion (CSII) in pregnancy.
    Van Ballegooie E; Visser GH; Laurini RN
    Neth J Med; 1985; 28 Suppl 1():3-6. PubMed ID: 4010841
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin therapy with microinfusion devices. Review of the literature].
    Bertone V; Locatelli A; Angeli G
    Minerva Med; 1987 Jan; 78(2):107-15. PubMed ID: 3808403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Where are we with the treatment of the diabetic using the insulin pump?].
    Lefèbvre P; Scheen A
    Acta Clin Belg; 1986; 41(4):229-40. PubMed ID: 3799131
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion: the insulin pump.
    De Nobel E
    Neth J Med; 1984; 27(5):173-6. PubMed ID: 6374480
    [No Abstract]   [Full Text] [Related]  

  • 9. 36 months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM)--influence on early stages of retinopathy, nephropathy and neuropathy--psychological analysis.
    Bibergeil H; Hüttl I; Felsing W; Felsing U; Seidlein I; Herfurth S; Dabels J; Reichel G; Lüder C; Albrecht G
    Exp Clin Endocrinol; 1987 Aug; 90(1):51-61. PubMed ID: 3666060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy.
    Guinn TS; Bailey GJ; Mecklenburg RS
    Diabetes Care; 1988 Jan; 11(1):46-51. PubMed ID: 3123187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of self monitoring of blood glucose (SMBG) and continuous subcutaneous insulin infusion (CSII) in diabetic pregnant women].
    Murata K; Toyoda N; Ito M; Rii T; Sugiyama Y; Miyamura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2749-57. PubMed ID: 4086905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of third-trimester diabetic pregnancies with the use of continuous subcutaneous insulin infusion therapy: a pilot study.
    Hertz RH; King KC; Kalhan SC
    Am J Obstet Gynecol; 1984 Jun; 149(3):256-60. PubMed ID: 6731504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
    Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
    Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of automatic systems for correcting blood sugar in patients with type-1 diabetes mellitus].
    Perelygina AA; Antsiferov MB; Starostina EG
    Probl Endokrinol (Mosk); 1988; 34(3):37-46. PubMed ID: 3138684
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin infusion therapy. Potential benefits and risks.
    Bonner RA
    Postgrad Med; 1985 May; 77(6):153-64. PubMed ID: 3921945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus guidelines for the management of insulin-dependent (type 1) diabetes. European IDDM Policy Group 1993.
    Diabet Med; 1993 Dec; 10(10):990-1005. PubMed ID: 8306599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.